Acasti Pharma Inc Share Price Toronto S.E.
Equities
APO
CA00430K1057
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2025 * | - | Sales 2026 * | 1.23M 898K 74.88M | Capitalization | 37.56M 27.44M 2.29B |
---|---|---|---|---|---|
Net income 2025 * | -23M -16.8M -1.4B | Net income 2026 * | -26M -18.99M -1.58B | EV / Sales 2025 * | - |
Net cash position 2025 * | - 0 0 | Net cash position 2026 * | - 0 0 | EV / Sales 2026 * | 30.6 x |
P/E ratio 2025 * |
-2.69
x | P/E ratio 2026 * |
-2.87
x | Employees | - |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 83.98% |
Latest transcript on Acasti Pharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/21/01 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/23/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10/23/10 |
Director/Board Member | - | 10/23/10 | |
Santosh Kottayil
BRD | Director/Board Member | 60 | 10/23/10 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- ACST Stock
- APO Stock